Cargando…

Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

BACKGROUND: KRAS was reported to affect some metabolic genes and promote metabolic reprogramming in solid tumors. However, there was no comprehensive analysis to explore KRAS-associated metabolic signature or risk model for pancreatic cancer (PC). METHODS: In the current study, multiple bioinformati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zuyi, Li, Zhenchong, Ma, Zuguang, Zhou, Zixuan, Zhuang, Hongkai, Liu, Chunsheng, Huang, Bowen, Zou, Yiping, Zheng, Zehao, Yang, LinLing, Gong, Yuanfeng, Huang, Shanzhou, Zhou, Qi, Zhang, Chuanzhao, Hou, Baohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516536/ https://www.ncbi.nlm.nih.gov/pubmed/34660806 http://dx.doi.org/10.1155/2021/9949272

Ejemplares similares

Identification of Prognostic and Therapeutic Biomarkers among FAM83 Family Members for Pancreatic Ductal Adenocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer
por: Zhou, Zixuan, et al.
Publicado: (2021)

A Novel Prognostic Nomogram for Gallbladder Cancer after Surgical Resection: A Single-Center Experience
por: Ma, Zuyi, et al.
Publicado: (2021)

Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021)

Identification of MBOAT2 as an Unfavorable Biomarker Correlated with KRAS Activation and Reduced CD8(+) T-Cell Infiltration in Pancreatic Cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway
por: Ma, Zuyi, et al.
Publicado: (2022)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Zhuang, Hongkai, et al.
Publicado: (2021)

B3GNT3 overexpression promotes tumor progression and inhibits infiltration of CD8(+) T cells in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

A four prognosis-associated lncRNAs (PALnc) based risk score system reflects immune cell infiltration and predicts patient survival in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer
por: Li, Zhenchong, et al.
Publicado: (2022)

Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Prognostic values and immune suppression of the S100A family in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2021)

A hierarchical prognostic model for Co-diabetes pancreatic adenocarcinoma
por: Wu, Zelong, et al.
Publicado: (2023)

Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2022)

Incidental intraoperative finding of gallbladder duplication in a patient with a choledochal cyst
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma
por: Huang, Shanzhou, et al.
Publicado: (2020)

GTF2IRD1 overexpression promotes tumor progression and correlates with less CD8(+) T cells infiltration in pancreatic cancer
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report
por: Zhuang, Hongkai, et al.
Publicado: (2020)

Down‐regulated lncRNA SBF2‐AS1 in M2 macrophage‐derived exosomes elevates miR‐122‐5p to restrict XIAP, thereby limiting pancreatic cancer development
por: Yin, Zi, et al.
Publicado: (2020)

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection
por: Zhang, Chuanzhao, et al.
Publicado: (2019)

Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma
por: Ma, Zuyi, et al.
Publicado: (2023)

Comparative safety and effectiveness of ultrasound-guided radiofrequency ablation combined with preoperative three-dimensional reconstruction versus surgical resection for solitary hepatocellular carcinoma of 3-5 cm
por: Gong, Yuanfeng, et al.
Publicado: (2019)

Acute obstructive cholangitis due to fishbone in the common bile duct: a case report and review of the literature
por: Yu, Min, et al.
Publicado: (2019)

Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
por: Yin, Zi, et al.
Publicado: (2021)

Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway
por: Yin, Zi, et al.
Publicado: (2019)

Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity
por: Luo, Yongde, et al.
Publicado: (2021)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
por: Yu, Shuang-Ni, et al.
Publicado: (2016)

Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome
por: Lemstrova, Radmila, et al.
Publicado: (2017)

Genome-Wide Profiling of Prognostic Alternative Splicing Pattern in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2019)

The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis
por: Jin, Liang, et al.
Publicado: (2020)

USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
por: Hou, Pingping, et al.
Publicado: (2021)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

Kras mutation correlating with circulating regulatory T cells predicts the prognosis of advanced pancreatic cancer patients
por: Cheng, He, et al.
Publicado: (2020)

Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
por: Zhu, Liang, et al.
Publicado: (2022)

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection
por: Li, Dezhi, et al.
Publicado: (2018)

Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma
por: Cheng, Lei, et al.
Publicado: (2015)

Ubiquitin‐independent, Proteasome‐mediated targeted degradation of KRAS in pancreatic adenocarcinoma cells using an engineered ornithine decarboxylase/antizyme system
por: Ma, Yihui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4b62pjmfegobmts0hicagdlb87